| scholarly article | Q13442814 |
| P2093 | author name string | Seung Kew Yoon | |
| Kwang-Hyub Han | |||
| Young-Suk Lim | |||
| Kwan Sik Lee | |||
| Seung Woon Paik | |||
| Kwan Soo Byun | |||
| Dong Jin Suh | |||
| Han Chu Lee | |||
| Yung Sang Lee | |||
| Nae-Yun Heo | |||
| Kang Mo Kim | |||
| P2860 | cites work | Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 |
| Treatment responses in Asians and Caucasians with chronic hepatitis C infection | Q27489011 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| A comparison of the natural history and outcome of treatment for Asian and non-Asian hepatitis C-infected patients. | Q50532082 | ||
| Hepatitis C: global prevalence | Q73914212 | ||
| The value of observational research in liver diseases | Q83258931 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 | ||
| Telaprevir for previously untreated chronic hepatitis C virus infection | Q29619800 | ||
| The global burden of hepatitis C | Q29620138 | ||
| Boceprevir for untreated chronic HCV genotype 1 infection | Q29620617 | ||
| A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Q30403548 | ||
| Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism | Q33361381 | ||
| Hepatitis C: role of the advanced practice nurse | Q33949337 | ||
| Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research | Q35008754 | ||
| Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study | Q36006322 | ||
| Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1. | Q37449527 | ||
| Efficacy of chronic hepatitis C therapy in community-based trials | Q37485031 | ||
| Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients | Q39913723 | ||
| The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients | Q42990027 | ||
| Response to pegylated interferon and ribavirin in Asian American patients with chronic hepatitis C genotypes 1 vs 2/3 vs 6. | Q42993494 | ||
| Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations | Q43000769 | ||
| Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment | Q43034816 | ||
| Impact of reducing peginterferon alfa-2a and ribavirin dose during retreatment in patients with chronic hepatitis C. | Q43035294 | ||
| Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in Asian patients | Q43036146 | ||
| Impact of Hispanic or Asian ethnicity on the treatment outcomes of chronic hepatitis C: results from the WIN-R trial | Q43039666 | ||
| Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. | Q43040369 | ||
| Southeast Asian patients with chronic hepatitis C: the impact of novel genotypes and race on treatment outcome | Q43040635 | ||
| Inferior response of Asian vs non-Asian hepatitis C genotype 3 infection to combination antiviral therapy | Q43047742 | ||
| Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C. | Q43244698 | ||
| Polymorphism near the IL28B gene in Korean hepatitis C virus-infected patients treated with peg-interferon plus ribavirin | Q45363470 | ||
| Impact of asian race on response to combination therapy with peginterferon alfa-2a and ribavirin in chronic hepatitis C. | Q46866205 | ||
| Differences in treatment outcome for hepatitis C among ethnic groups | Q46920864 | ||
| Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice | Q47669754 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | peginterferon alfa-2a | Q420056 |
| ribavirin | Q421862 | ||
| chronic hepatitis C | Q55779873 | ||
| P304 | page(s) | 60-69 | |
| P577 | publication date | 2013-03-25 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice | |
| P478 | volume | 19 |
| Q43199205 | Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C? |
| Q31149778 | Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b. |
| Q33905607 | No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients |
| Q53079597 | Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C. |
| Q40781856 | Treatment Response and Long-Term Outcome of Peginterferon α and Ribavirin Therapy in Korean Patients with Chronic Hepatitis C. |
Search more.